9家千亿市值公司候场 2026年港股IPO热潮延续

Group 1 - The core viewpoint of the news is that the Hong Kong IPO market is experiencing significant growth, with a notable increase in the number of new listings and total fundraising amounts in 2026 [1][2][4] - As of February 5, 2026, there have been 15 new IPOs in Hong Kong, representing a year-on-year increase of 87.50%, with total fundraising reaching 51.307 billion HKD, up 757.71% [1] - Eastroc Beverage has become the first IPO in Hong Kong for 2026 to raise over 10 billion HKD, totaling 10.1 billion HKD [1] Group 2 - The "2025 Hong Kong IPO Market and Secondary Market White Paper" indicates that there are over 270 companies planning to list, with 277 valid applications as of December 31, 2025 [2][3] - The majority of these applications are concentrated in the software services, healthcare, and industrial manufacturing sectors, accounting for over 60% of the total [3] - The average number of submissions per company is 1.4, indicating a strong influx of new companies into the Hong Kong market [3] Group 3 - Multiple institutions predict that the Hong Kong IPO market will remain robust in 2026, with estimates ranging from 150 to 200 new listings and total fundraising between 300 billion to 350 billion HKD [5] - Deloitte forecasts approximately 160 new IPOs with a minimum fundraising of 300 billion HKD, while PwC expects around 150 listings with total fundraising between 320 billion to 350 billion HKD [5] Group 4 - In 2025, A-share companies were a significant source for the Hong Kong IPO market, with 19 new A+H companies listed, raising a total of 126.946 billion HKD [6][7] - There are currently 93 A-share companies that have submitted applications to list in Hong Kong, including 10 with a market capitalization exceeding 100 billion RMB [7] Group 5 - The trend of leading mainland enterprises and A+H new stocks listing in Hong Kong is expected to continue in 2026, driven by the demand for international financing channels [8] - The influx of A-share companies is enhancing the quality and attractiveness of the Hong Kong capital market, providing stable cash flow and clear growth logic [8] Group 6 - Recent reforms by the Hong Kong Stock Exchange, including the introduction of the 18A and 18C rules, have significantly increased the market's appeal, particularly for biotech and technology companies [10][12] - The 18A rule has led to a rise in biotech listings, with 16 companies listed in 2025, and 27 companies currently applying under this rule [10][14] - The 18C rule has also attracted numerous unprofitable tech companies, with 5 companies listed in 2025 and a total fundraising of 59.15 billion HKD [13][14]